Cancer, Parkinson's and motor neurone patients could get major savings after three new drugs were listed on the Pharmaceutical Benefits Scheme.
The federal government will spend $19 million to list the medicines on the PBS, with patients able to access them for $40.30 per script or $6.50 with a concession card from April.
The listing of Adcetris will be broadened to treat a rare from of cancer which affects about 150 to 200 Australian each year called cutaneous T-cell lymphomas.
